DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Pfizer
Fate Therapeutics
University of Nebraska
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital